A new EU project, METSY, develops and applies neuroimaging and bioinformatics tools to study how lipid metabolism is connected to psychotic disorders and metabolic co-morbidities such as metabolic syndrome and diabetes.
The overall objective is to identify, prioritize and evaluate multi-modal blood and neuroimaging biomarkers that have diagnostic potential for prediction and monitoring psychotic disorders and associated metabolic co-morbidities. The consortium brings together clinicians, researchers and industry partners in the domains of psychiatry, neuroimaging, metabolic research, systems biology and bioinformatics.
The 4-year EU-project is coordinated by Research Professor Matej Orešič from VTT Technical Research Centre of Finland. Total budget for the project is € 5.94 million €, of which the EU's share is € 4.23 million.
Project partners: VTT Technical Research Centre of Finland, Biomax Informatics AG (Germany), Servicio Madrileño de Salud (Spain), University of Turku (Finland), National Institute for Health and Welfare (Finland), Philips Research (Germany), King's College London (UK).
VTT Technical Research Centre of Finland
Research Professor Matej Orešič
tel. +358 20 722 4491, firstname.lastname@example.org
Further information on VTT:
VTT Technical Research Centre of Finland is a leading multitechnological applied research organization in Northern Europe. VTT creates new technology and science-based innovations in co-operation with domestic and foreign partners. VTT's turnover is EUR 290 million and its personnel totals 3,100.